Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.661
https://www.valueinhealthjournal.com/article/S1098-3015(14)00712-8/fulltext
Section Title :
Cardiovascular Disorders
Section Order :
90
First Page :
A113
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00712-8&doi=10.1016/j.jval.2014.03.661